In the News

  • September 9, 2020
  • Haemonetics To Present At The 18th Annual Morgan Stanley Global Healthcare Conference
    View details
  • August 7, 2020
  • Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting
    View details
  • August 4, 2020
  • Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor Relations Website
    View details
  • July 24, 2020
  • Haemonetics Announces Sale Of Inlog Holdings France SAS To Abénex Capital
    View details
  • July 6, 2020
  • Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2021 Results: August 4, 2020
    View details
  • July 2, 2020
  • Haemonetics Statement on the Safety of Our Blood and Plasma Collection Devices
    View details
  • June 30, 2020
  • Haemonetics Announces 2020 Annual Meeting Of Shareholders Will Be Conducted In Virtual Format
    View details
  • June 3, 2020
  • Haemonetics Announces Blood Filter Supply Agreement And Sale Of Puerto Rico-Based Manufacturing Operations To GVS, S.p.A
    View details
  • May 28, 2020
  • Haemonetics Announces Sale Of U.S. Blood Donor Management Software Solution Assets To The GPI Group
    View details
  • May 6, 2020
  • Haemonetics Announces Commitment to COVID-19 Relief Efforts
    View details
  • May 5, 2020
  • Haemonetics 4th Quarter and Fiscal 2020 Earnings Release Available on Investor Relations Website
    View details
  • April 17, 2020
  • Michael Coyle Joins Haemonetics Board of Directors
    View details
  • April 3, 2020
  • Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2020 Results: May 5, 2020
    View details
  • April 2, 2020
  • Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
    View details
  • March 30, 2020
  • Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer
    View details
  • March 14, 2020
  • Haemonetics statement on business continuity in response to COVID-19
    View details
  • February 4, 2020
  • Haemonetics 3rd Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website
    View details
  • January 14, 2020
  • Haemonetics Announces Acquisition Of Intellectual Property Assets Relating To TEG® 6s Hemostasis Analyzer System
    View details
View News by Year
UPDATE RESULTS